Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05313685
Other study ID # 21-012057
Secondary ID
Status Completed
Phase
First received
Last updated
Start date December 6, 2021
Est. completion date March 25, 2022

Study information

Verified date June 2022
Source Mayo Clinic
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This is a research study about hiccup educational materials. The purpose of this study is to learn whether this type of research can be done.


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date March 25, 2022
Est. primary completion date February 23, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age = 18 years of age. - Hiccups in the 4 weeks prior to phone contact (patient must confirm). - Able to speak and read English. - Has an e-mail address. Exclusion Criteria: - Individuals < 18 years of age.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United States Mayo Clinic Rochester Rochester Minnesota

Sponsors (1)

Lead Sponsor Collaborator
Mayo Clinic

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Feasibility of enrollment This is a feasibility study that seeks to enroll 20 patients with hiccups in 5 months from the start of trial recruitment. 5 months
See also
  Status Clinical Trial Phase
Recruiting NCT05749159 - New Physitherapy or Alternative Therapy for Hiccup N/A
Withdrawn NCT01277731 - Methylprednisolone Replacement for Dexamethasone-induced Hiccup N/A
Not yet recruiting NCT03778281 - Treatment of Chemotherapy-related Hiccups With Baclofen Phase 4

External Links